---
category: news
title: "BERG To Conduct Phase Two Trial For Treatment Of Deadly Glioblastoma Multiforme [GBM]"
excerpt: "BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today announced with leading cancer centers that the Federal Drug Administration [FDA] has authorized a phase 2 trial in glioblastoma multiforme [GBM] patients in neo-adjuvant settings using BERGâ€™s BPM 31510."
publishedDateTime: 2021-03-22T18:01:00Z
originalUrl: "https://apnews.com/press-release/pr-newswire/science-business-medical-research-corporate-news-biology-1c39adcc9055b0496cf46fefc70205ed"
webUrl: "https://apnews.com/press-release/pr-newswire/science-business-medical-research-corporate-news-biology-1c39adcc9055b0496cf46fefc70205ed"
type: article
quality: 17
heat: 17
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "4wnKEbbfgt1PTaszowTKjBNjmWTcRXjwDn8TMATXSiN0W4Kfqgjd7vqM6QewfK1M7aXBH71B0DvROWo2C1NGNza99a+RWX0cLHhhnllC1PJ/YvD7oaZVKOynSwoyHqvMkcdZNgdqoDsKpruPWhJrxmBQ7RiMtScZSWVtllEawrH/oNeR6AWAz6SLhKD84YEpTJcBHjjBNExMIvqr0vhEiLr/2puL89+McPm6qc9htOAmwgNuPsqteF5EYsUAhg4tj5JfFs3q5W/48uhCADaHDWFcn8i6G0A8pjneNVlIIFSBZkrP7UdWbahiQDr4dXOGf6zJbL5JKuIFpTE2nq5YQrCm3+Nm13u/cXYjK6fSrk4=;1FIDDOIhps7G/u1ISsb3ig=="
---

